JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Serres, F.
Right arrow Articles by Van de Kar, L. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Serres, F.
Right arrow Articles by Van de Kar, L. D.

Vol. 294, Issue 1, 296-301, July 2000

Coadministration of 5-Hydroxytryptamine1A Antagonist WAY-100635 Prevents Fluoxetine-Induced Desensitization of Postsynaptic 5-Hydroxytryptamine1A Receptors in Hypothalamus1

Florence Serres2, Nancy A. Muma, Daní K. Raap3, Francisca Garcia, George Battaglia and Louis D. Van de Kar

Loyola University of Chicago, Stritch School of Medicine, Department of Pharmacology, Maywood, Illinois

Treatment with selective serotonin reuptake inhibitors induces a desensitization of hypothalamic postsynaptic 5-hydroxytryptamine (5-HT)1A receptors in humans and rats. This study investigated whether fluoxetine-induced desensitization is due to overactivation of postsynaptic 5-HT1A receptors; whether blockade of somatodendritic 5-HT1A autoreceptors accelerates this desensitization; and whether desensitization is associated with a reduction of Gz proteins, which couple to 5-HT1A receptors. WAY-100635 was tested at low doses (0.03-0.3 mg/kg), which antagonize somatodendritic 5-HT1A autoreceptors in the raphe nuclei, and at a higher dose (1 mg/kg), which completely blocks postsynaptic 5-HT1A receptors. Plasma levels of oxytocin and adrenal corticotrophic hormone (corticotropin) were measured as peripheral indicators of hypothalamic 5-HT1A receptor function. Daily injections of fluoxetine (10 mg/kg/day i.p.) for 2 days did not desensitize 5-HT1A receptors but three daily injections of fluoxetine produced a partial desensitization of the hormone responses to (±)-8-hydroxy-2-dipropylaminoetetralin (50 µg/kg s.c.). WAY-100635 (0.03-0.3 mg/kg) did not accelerate or potentiate the fluoxetine-induced desensitization of 5-HT1A receptors. However, WAY-100635 at a dose that completely blocks postsynaptic 5-HT1A receptors (1.0 mg/kg) completely prevented the fluoxetine-induced desensitization of 5-HT1A receptors. These data demonstrate that at least 3 days of fluoxetine exposure is required to produce a homologous desensitization of hypothalamic 5-HT1A receptors. Although previous studies indicate that injections of fluoxetine for 14 days produce a reduction of Gz protein levels in the hypothalamus, the levels of Gz proteins were not affected by either fluoxetine or WAY-100635. Alternative mechanisms mediating the initial stages of 5-HT1A receptor desensitization could involve post-translational modifications in the 5-HT1A receptor-Gz protein-signaling cascade.


1 This study was supported in part by U.S. Public Health Service Grants NS34153 (to L.D.V.D.K.) and NS38509 (to N.A.M.), National Alliance for Research on Schizophrenia and Depression (to D.K.R.), and the Loyola University Neuroscience and Aging Institute postdoctoral program (to F.S.).

2 Current address: Lilly Research Centre, Erl Wood Manor, Sunninghill Rd., Windlesham Surrey GU20 6PH, UK.

3 Current address: Department of Psychology, University of Alaska Fairbanks, Fairbanks, AK 99775.


0022-3565/00/2941-0296$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Neurosci.Home page
C. Alexandre, D. Popa, V. Fabre, S. Bouali, P. Venault, K.-P. Lesch, M. Hamon, and J. Adrien
Early life blockade of 5-hydroxytryptamine 1A receptors normalizes sleep and depression-like behavior in adult knock-out mice lacking the serotonin transporter.
J. Neurosci., May 17, 2006; 26(20): 5554 - 5564.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.